Peroxisome proliferator-activated receptors alpha, beta, and gamma mRNA and protein expression in human fetal tissues

PPAR Research

Volumn , Issue , 2010, Pages

  Abbott, Barbara D ^a   Wood, Carmen R ^a   Watkins, Andrew M ^a   Das, Kaberi P ^a   Lau, Christopher S ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADRENAL GLAND; ADULT; ARTICLE; CONTROLLED STUDY; FETUS; FETUS (ANATOMY); FETUS DEVELOPMENT; HEART; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE; KIDNEY PARENCHYMA; LIVER; LUNG PARENCHYMA; PROTEIN EXPRESSION; SPLEEN; STOMACH; THYMUS;

EID: 77956803359     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2010/690907     Document Type: Article

References (42)

1. Desvergne B., Wahli W., Peroxisome proliferator-activated receptors: nuclear control of metabolism Endocrine Reviews 1999 20 5 649 688
2. Keller H., Devchand P. R., Perroud M., Wahli W., PPAR structure-function relationships derived from species-specific differences in responsiveness to hypolipidemic agents Biological Chemistry 1997 378 7 651 655
3. Michalik L., Desvergne B., Dreyer C., Gavillet M., Laurini R. N., Wahli W., PPAR expression and function during vertebrate development International Journal of Developmental Biology 2002 46 1 105 114
4. Escher P., Wahli W., Peroxisome proliferator-activated receptors: insight into multiple cellular functions Mutation Research 2000 448 2 121 138
5. Barak Y., Kim S., Genetic manipulations of PPARs: effects on obesity and metabolic disease PPAR Research 2007 2007 12
6. Gurnell M., 'Striking the right balance' in targeting PPAR in the metabolic syndrome: novel insights from human genetic studies PPAR Research 2007 2007 14
7. Rees W. D., McNeil C. J., Maloney C. A., The roles of PPARs in the fetal origins of metabolic health and disease PPAR Research 2008 2008 8
8. Semple R. K., Chatterjee V. K. K., O'Rahilly S., PPAR and human metabolic disease Journal of Clinical Investigation 2006 116 3 581 589
9. Barak Y., Liao D., He W., Ong E. S., Nelson M. C., Olefsky J. M., Boland R., Evans R. M., Effects of peroxisome proliferator-activated receptor on placentation, adiposity, and colorectal cancer Proceedings of the National Academy of Sciences of the United States of America 2002 99 1 303 308
10. Barak Y., Nelson M. C., Ong E. S., Jones Y. Z., Ruiz-Lozano P., Chien K. R., Koder A., Evans R. M., PPAR is required for placental, cardiac, and adipose tissue development Molecular Cell 1999 4 4 585 595
11. Tan N. S., Michalik L., Desvergne B., Wahli W., Multiple expression control mechanisms of peroxisome proliferator-activated receptors and their target genes Journal of Steroid Biochemistry and Molecular Biology 2005 93 25 99 105
12. Goya K., Sumitani S., Otsuki M., Xu X., Yamamoto H., Kurebayashi S., Saito H., Kouhara H., Kasayama S., The thiazolidinedione drug troglitazone up-regulates nitric oxide synthase expression in vascular endothelial cells Journal of Diabetes and Its Complications 2006 20 5 336 342
13. Klaunig J. E., Babich M. A., Baetcke K. P., Cook J. C., Corton J. C., David R. M., DeLuca J. G., Lai D. Y., McKee R. H., Peters J. M., Roberts R. A., Fenner-Crisp P. A., PPAR agonist-induced rodent tumors: modes of action and human relevance Critical Reviews in Toxicology 2003 33 6 655 780
14. Zoete V., Grosdidier A., Michielin O., Peroxisome proliferator-activated receptor structures: ligand specificity, molecular switch and interactions with regulators Biochimica et Biophysica Acta 2007 1771 8 915 925
15. Andersen M. E., Butenhoff J. L., Chang S.-C., Farrar D. G., Kennedy G. L. Jr., Lau C., Olsen G. W., Seed J., Wallace K. B., Perfluoroalkyl acids and related chemistriestoxicokinetics and modes of action Toxicological Sciences 2008 102 1 3 14
16. Lau C., Anitole K., Hodes C., Lai D., Pfahles-Hutchens A., Seed J., Perfluoroalkyl acids: a review of monitoring and toxicological findings Toxicological Sciences 2007 99 2 366 394
17. Lau C., Anitole K., Hodes C., Lai D., Pfahles-Hutchens A., Seed J., Perfluoroalkyl acids: a review of monitoring and toxicological findings Toxicological Sciences 2007 99 2 366 394
18. Wolf C. J., Fenton S. E., Schmid J. E., Calafat A. M., Kuklenyik Z., Bryant X. A., Thibodeaux J., Das K. P., White S. S., Lau C. S., Abbott B. D., Developmental toxicity of perfluorooctanoic acid in the CD-1 mouse after cross-foster and restricted gestational exposures Toxicological Sciences 2007 95 2 462 473
19. Lau C., Thibodeaux J. R., Hanson R. G., Narotsky M. G., Rogers J. M., Lindstrom A. B., Strynar M. J., Effects of perfluorooctanoic acid exposure during pregnancy in the mouse Toxicological Sciences 2006 90 2 510 518
20. Lau C., Thibodeaux J. R., Hanson R. G., Rogers J. M., Grey B. E., Stanton M. E., Buttenhoff J. L., Stevenson L. A., Exposure to perfluorooctane sulfonate during pregnancy in rat and mouse. II: postnatal evaluation Toxicological Sciences 2003 74 2 382 392 (Pubitemid 36958307)
21. Lau C., Butenhoff J. L., Rogers J. M., The developmental toxicity of perfluoroalkyl acids and their derivatives Toxicology and Applied Pharmacology 2004 198 2 231 241
22. Luebker D. J., Case M. T., York R. G., Moore J. A., Hansen K. J., Butenhoff J. L., Two-generation reproduction and cross-foster studies of perfluorooctanesulfonate (PFOS) in rats Toxicology 2005 215 1-2 126 148
23. Luebker D. J., York R. G., Hansen K. J., Moore J. A., Butenhoff J. L., Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in Sprague-Dawley rats: dose-response, and biochemical and pharamacokinetic parameters Toxicology 2005 215 1-2 149 169
24. Abbott B. D., Wolf C. J., Schmid J. E., Das K. P., Zehr R. D., Helfant L., Nakayama S., Lindstrom A. B., Strynar M. J., Lau C., Perfluorooctanoic acid-induced developmental toxicity in the mouse is dependent on expression of peroxisome proliferator-activated receptor-alpha Toxicological Sciences 2007 98 2 571 581
25. Wolf C. J., Lau C., Abbott B. D., Developmental effects of perfluorononanoic acid are dependent on peroxisome proliferator-activated receptor-alpha The Toxicologist 2009 108 1 353
26. Abbott B. D., Review of the expression of peroxisome proliferator- activated receptors alpha (PPAR ), beta (PPAR ), and gamma (PPAR ) in rodent and human development Reproductive Toxicology 2009 27 3-4 246 257
27. Rosen M. B., Abbott B. D., Wolf D. C., Corton J. C., Wood C. R., Schmid J. E., Das K. P., Zehr R. D., Blair E. T., Lau C., Gene profiling in the livers of wild-type and PPAR -null mice exposed to perfluorooctanoic acid Toxicologic Pathology 2008 36 4 592 607
28. Rosen M. B., Schmid J. E., Das K. P., Wood C. R., Zehr R. D., Lau C., Gene expression profiling in the liver and lung of perfluorooctane sulfonate-exposed mouse fetuses: comparison to changes induced by exposure to perfluorooctanoic acid Reproductive Toxicology 2009 27 3-4 278 288
29. Rosen M. B., Thibodeaux J. R., Wood C. R., Zehr R. D., Schmid J. E., Lau C., Gene expression profiling in the lung and liver of PFOA-exposed mouse fetuses Toxicology 2007 239 1-2 15 33
30. Huin C., Corriveau L., Bianchi A., Keller J. M., Collet P., Krmarik-Bouillaud P., Domenjoud L., Bcuwe P., Schohn H., Mnard D., Daua M., Differential expression of peroxisome proliferator-activated receptors (PPARs) in the developing human fetal digestive tract Journal of Histochemistry and Cytochemistry 2000 48 5 603 611
31. Apelberg B. J., Witter F. R., Herbstman J. B., Calafat A. M., Halden R. U., Needham L. L., Goldman L. R., Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth Environmental Health Perspectives 2007 115 11 1670 1676
32. Harada K., Saito N., Inoue K., Yoshinaga T., Watanabe T., Sasaki S., Kamiyama S., Koizumi A., The influence of time, sex and geographic factors on levels of perfluorooctane sulfonate and perfluorooctanoate in human serum over the last 25 years Journal of Occupational Health 2004 46 2 141 147
33. Karrman A., Ericson I., van Bavel B., Exposure of perfluorinated chemicals through lactation: levels of matched human milk and serum and a temporal trend, 19962004, in Sweden Environmental Health Perspectives 2007 115 2 226 230
34. Kuklenyik Z., Reich J. A., Tully J. S., Needham L. L., Calafat A. M., Automated solid-phase extraction and measurement of perfluorinated organic acids and amides in human serum and milk Environmental Science and Technology 2004 38 13 3698 3704
35. Butenhoff J. L., Gaylor D. W., Moore J. A., Olsen G. W., Rodricks J., Mandel J. H., Zobel L. R., Characterization of risk for general population exposure to perfluorooctanoate Regulatory Toxicology and Pharmacology 2004 39 3 363 380
36. So M. K., Yamashita N., Taniyasu S., Jiang Q., Giesy J. P., Chen K., Lam P. K. S., Health risks in infants associated with exposure to perfluorinated compounds in human breast milk from Zhoushan, China Environmental Science and Technology 2006 40 9 2924 2929
37. Sadler T. W., Langman's Medical Embryology 2000 8th Baltimore, Md, USA Lippincott Willians Wilkins
38. Abbott B. D., Probst M. R., Perdew G. H., Buckalew A. R., AH receptor, ARNT, glucocorticoid receptor, EGF receptor, EGF, TGF, TGF 1, TGF 2, and TGF 3 expression in human embryonic palate, and effects of 2,3,7,8-tetrachlorodibenzo- p-dioxin (TCDD) Teratology 1998 58 2 30 43
39. Beck F., Plummer S., Senior P. V., Byrne S., Green S., Brammar W. J., The ontogeny of peroxisome-proliferator-activated receptor gene expression in the mouse and rat Proceedings of the Royal Society B 1992 247 1319 83 87
40. Keller J. M., Collet P., Bianchi A., Huin C., Bouillaud-Kremarik P., Becuwe P., Schohn H., Domenjoud L., Dauca M., Implications of peroxisome proliferator-activated receptors (PPARS) in development, cell life status and disease International Journal of Developmental Biology 2000 44 5 429 442
41. Braissant O., Wahli W., Differential expression of peroxisome proliferator-activated receptor-,-, and- during rat embryonic development Endocrinology 1998 139 6 2748 2754
42. Yang T., Michele D. E., Park J., Smart A. M., Lin Z., Brosius F. C. III, Schnermann J. B., Briggs J. P., Expression of peroxisomal proliferator-activated receptors and retinoid X receptors in the kidney American Journal of Physiology 1999 277 6 F966 F973